Zusammenfassung
Hintergrund
In der Notfallmedizin stellt das Alkoholentzugsdelir ein häufiges Krankheitsbild dar. Basis für die Erkennung bleibt eine genaue und vorurteilsfreie Anamnese und Befunderhebung.
Ergebnisse und Schlussfolgerung
Die Therapie erfolgt symptomadaptiert. Grundlage bleibt die Therapie mit GABAergen Substanzen wie Benzodiazepinen und Clomethiazol sowie die Gabe von Vitamin B 1 . Durch eine frühzeitige Behandlung und Erkennung der Komplikationen wie Entzugsanfällen, intrakraniellen Blutungen, Elektrolytstörungen, der Wernicke-Enzephalopathie und kardialen Rhythmusstörungen kann die Prognose deutlich verbessert werden.
Abstract
Background
Alcohol withdrawal syndrome is often seen in emergency medicine. Mandatory for diagnosis is the accurate and unprejudiced anamnesis.
Results and conclusion
Treatment should be based on symptoms. Fundamental for treatment is administration of GABA receptor-stimulating substances like benzodiazepines and clomethiazol, as well as vitamin B1. Early identification and treatment of complications (e.g., seizures, intracranial hemorrhage, electrolyte disturbance, Wernicke encephalopathy, and cardiac arrhythmias) improves the prognosis significantly.
Abbreviations
- CCT:
-
Zerebrale Computertomographie
- GABA:
-
γ-Aminobuttersäure
- CIWA-Ar:
-
„Revised clinical institute withdrawal assessment for alcohol scale“
- DT:
-
Delirium tremens
- PAWSS:
-
„Predicition of alcohol withdrawal severity scale“
Literatur
Amato L, Minozzi S, Vecchi S, Davoli M (2010) Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2010 Mar 17;(3):CD005063
Amato L, Minozzi S, Davoli M (2011) Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome. Cochrane Database Syst Rev (6):CD008537
Awissi DK, Lebrun G, Fagnan M, Skrobik Y, Regroupement de Soins Critiques, Réseau de Soins Respiratoires (2013) QuébecAlcohol, nicotine, and iatrogenic withdrawals in the ICU. Crit Care Med 41(9 Suppl 1):S57–S68
Carey MG, Al-Zaiti SS, Kozik TM, Pelter M (2014) Holiday heart syndrome. Am J Crit Care 23(2):171–172
Darvishi N, Farhadi M, Haghtalab T, Poorolajal J (2015) Alcohol-related risk of suicidal ideation, suicide attempt, and completed suicide: a meta-analysis. PLoS One 10(5):e0126870
Deik A, Saunders-Pullmann R, San Luciano M (2012) Substances of abuse and movement disorders: complex interactons and comorbidities. Curr Drug Abuse Rev 5(3):243–253
Deutsche Hauptstelle für Suchtfragen. ww.dhs.de. Zugegriffen: 21. Juni 2015
D’Onofrio G, Rathlev NK, Ulrich AS, Fish SS, Freedland ES (1999) Lorazepam for the prevention of recurrent seizures related to alcohol. N Engl J Med 340(12):915–919
Elisaf M, Liberopoulos E, Bairaktari E, Siamopoulos K (2002) Hypokalaemia in alcoholic patients. Drug Alcohol Rev 21(1):73–76
Elisaf M, Merkouropoulos M, Tsianos EV, Siamopoulos KC (1994) Acid-base and electrolyte abnormalities in alcoholic patients. Miner Electrolyte Metab 20(5):274–281
Ferguson JA, Suelzer CJ, Eckert GJ, Zhou XH, Dittus RS (1996) Risk factors for delirium tremens development. J Gen Intern Med 11(7):410–414
Foy A, Kay J, Taylor A (1997) The course of alcohol withdrawal in a general hospital. QJM 90(4):253–261
Hammond CJ, Niciu MJ, Drew S, Arias AJ (2010) Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders. Eur Addict Res 16(4):179–184
http://www.awmf.org/uploads/tx_szleitlinien/030-006l_S1_Alkoholdelir_Verwirrheitszustaende_2012-verlaengert.pdf. Zugegriffen: 21. Juni 2015
Jaeger TM, Lohr RH, Pankratz VS (2001) Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clin Proc 76(7):695–701
John U, Hanke M (2002) Alcohol-attributable mortality in a high per capita consumption country – Germany. Alcohol Alcohol 37(6):581–585
Kosten TR, O’Connor PG (2003) Management of drug and alcohol withdrawal. N Engl J Med 348(18):1786–1795
Lizotte RJ, Kappes JA, Bartel BJ, Hayes KM, Lesselyoung VL (2014) Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal. Clin Pharmacol 6:171–177
Maldonado JR, Sher Y, Das S, Hills-Evans K, Frenklach A, Lolak S, Talley R, Neri E (2015) Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: a new scale for the prediction of complicated alcohol withdrawal syndrome. Alcohol Alcohol 50:509–518. pii: agv043
Maldonado JR, Nguyen LH, Schader EM, Brooks JO 3rd (2012) Benzodiazepine loading versus symptom-triggered treatment of alcohol withdrawal: a prospective, randomized clinical trial. Gen Hosp Psychiatry 34(6):611–617
Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278(2):144–151
McMicken D, Liss JL (2011) Alcohol-related seizures. Emerg Med Clin North Am 29(1):117–124
de Millas W, Ganzer F, Kuhn S, Haasen C (2010) Oxazepam versus clomethiazol in alcohol withdrawal treatment. Eur Addict Res 16(4):179–184
Minozzi S, Amato L, Vecchi S, Davoli M (2010) Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev (3):CD005064
Nanau RM, Neuman MG (2015) Biomolecules and Biomarkers Used in Diagnosis of Alcohol Drinking and in Monitoring Therapeutic Interventions. Biomolecules 5(3):1339–1385
Rathlev NK, D’Onofrio G, Fish SS, Harrison PM, Bernstein E, Hossack RW, Pickens L (1994) The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures. Ann Emerg Med 23(3):513–518
Richards JR, Albertson TE, Derlet RW, Lange RA, Olson KR, Horowitz BZ (2015) Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend 150:1–13
Schuckit MA (2015) Management of withdrawal delirium (delirium tremens). N Engl J Med 372(6):580–581
Sojka M (1996) Die Alkoholhalluzinose. Nervenarzt 67:891–895
Stuppaeck CH, Barnas C, Falk M, Guenther V, Hummer M, Oberbauer H, Pycha R, Whitworth AB, Fleischhacker WW (1994) Assessment of the alcohol withdrawal syndrome – validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A). Addiction 89(10):1287–1292
Sullivan JT, Sykora K, Schneidermann J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Add 84(11):1353–1357
Ungur LA, Neuner B, John S, Wernecke K, Spies C (2013) Prevention and therapy of alcohol withdrawal on intensive care units: systematic review of controlled trials. Prevention and therapy of alcohol withdrawal on intensive care units: systematic review of controlled trials. Alcohol Clin Exp Res 37(4):675–686
Uzbay IT, Akarsu ES, Kayaalp SO (1994) Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats. Pharmacol Biochem Behav 49(4):969–974
Victor M, Adams RD (1953) The effect of alcohol on the nervous system. Res Pub Assoc Res Nerv Mental Dis 32:525–572
Volpi-Abadie J, Kaye AM, Kaye AD (2013) Serotonin syndrome. Ochsner J 13(4):533–540
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
G. Haas gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Additional information
Redaktion
C. Jäkel, Lübben
S. Poloczek, Berlin
R. Somasundaram, Berlin
C. Wrede, Berlin
Rights and permissions
About this article
Cite this article
Haas, G. Alkoholentzugsdelir und akute Komplikationen. Notfall Rettungsmed 19, 22–27 (2016). https://doi.org/10.1007/s10049-015-0108-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10049-015-0108-7
Schlüsselwörter
- Alkoholentzugsdelir
- Benzodiazepine
- Alkoholentzugskrämpfe
- Symptomadaptierte Therapie
- Differenzialdiagnose Delir